Study of aggressive spinal hemangioma
Part of Cancer clinical trials.
This trial is for people who have been diagnosed with an aggressive spinal hemangioma, a non-cancerous tumor in the spine that can cause pain or nerve problems. It aims to study the condition and possibly test treatments to help manage symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have symptoms like pain or nerve issues caused by the spinal hemangioma.
- You need a confirmed diagnosis of aggressive spinal hemangioma based on imaging tests like MRI, CT, or angiography.
- You must not have been diagnosed incidentally (meaning it was found by accident during a check for something else).
- You need clear imaging evidence that confirms the aggressive spinal hemangioma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, SYHA1813, for people with a type of brain tumor called high-grade meningioma that has come back or gotten worse. The goal is to see if the drug can help control the tumor and improve outcomes.
This trial tests a new drug, SYHA1813, for people whose high-grade meningioma has come back or gotten worse after standard treatments like surgery and radiation. The goal is to see if this drug can help control the tumor and improve outcomes.
This trial tests a new drug, Hemay181, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it can shrink tumors and how safe it is.
This study collects information about people with spine cancer who have surgery to relieve pressure on the spine, followed by radiation therapy. The goal is to learn more about how well these treatments work together.
This trial studies a treatment using a special gelled alcohol to shrink aggressive angiomas (abnormal blood vessel growths). It aims to see if the procedure is safe, feasible, and works well.
This study looks at glioblastoma (GBM), a very aggressive brain tumor, and how “brain cell overload” (glutamate excitotoxicity) may affect tumor growth. It focuses on adults who are planned for complete tumor removal, followed by standard radiation and chemotherapy.
Hear when a new Aggressive Spinal Hemangiomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.